Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Naringenin Ameliorates Drosophila ReepA Hereditary Spastic Paraplegia-Linked Phenotypes.

Napoli B, Gumeni S, Forgiarini A, Fantin M, De Filippis C, Panzeri E, Vantaggiato C, Orso G.

Front Neurosci. 2019 Nov 19;13:1202. doi: 10.3389/fnins.2019.01202. eCollection 2019.

2.

Axially Ligated Mesohemins as Bio-Mimicking Catalysts for Atom Transfer Radical Polymerization.

Fu L, Simakova A, Park S, Wang Y, Fantin M, Matyjaszewski K.

Molecules. 2019 Nov 2;24(21). pii: E3969. doi: 10.3390/molecules24213969.

3.

Growing Polymer Brushes from a Variety of Substrates under Ambient Conditions by Cu0-Mediated Surface-Initiated ATRP.

Yan W, Fantin M, Ramakrishna S, Spencer ND, Matyjaszewski K, Benetti EM.

ACS Appl Mater Interfaces. 2019 Jul 31;11(30):27470-27477. doi: 10.1021/acsami.9b09529. Epub 2019 Jul 18.

PMID:
31276375
4.

Reductive Termination of Cyanoisopropyl Radicals by Copper(I) Complexes and Proton Donors: Organometallic Intermediates or Coupled Proton-Electron Transfer?

Thevenin L, Fliedel C, Fantin M, Ribelli TG, Matyjaszewski K, Poli R.

Inorg Chem. 2019 May 6;58(9):6445-6457. doi: 10.1021/acs.inorgchem.9b00660. Epub 2019 Apr 16.

PMID:
30990024
5.

Mechanistically Guided Predictive Models for Ligand and Initiator Effects in Copper-Catalyzed Atom Transfer Radical Polymerization (Cu-ATRP).

Fang C, Fantin M, Pan X, de Fiebre K, Coote ML, Matyjaszewski K, Liu P.

J Am Chem Soc. 2019 May 8;141(18):7486-7497. doi: 10.1021/jacs.9b02158. Epub 2019 Apr 29.

PMID:
30977644
6.

Redox-switchable atom transfer radical polymerization.

Dadashi-Silab S, Lorandi F, Fantin M, Matyjaszewski K.

Chem Commun (Camb). 2019 Jan 16;55(5):612-615. doi: 10.1039/c8cc09209e. Epub 2018 Dec 19.

PMID:
30565596
7.

Atom Transfer Radical Polymerization: Billion Times More Active Catalysts and New Initiation Systems.

Ribelli TG, Lorandi F, Fantin M, Matyjaszewski K.

Macromol Rapid Commun. 2019 Jan;40(1):e1800616. doi: 10.1002/marc.201800616. Epub 2018 Oct 30. Review.

PMID:
30375120
8.

Functional and Structural Brain Damage in Friedreich's Ataxia.

Vavla M, Arrigoni F, Nordio A, De Luca A, Pizzighello S, Petacchi E, Paparella G, D'Angelo MG, Brighina E, Russo E, Fantin M, Colombo P, Martinuzzi A.

Front Neurol. 2018 Sep 6;9:747. doi: 10.3389/fneur.2018.00747. eCollection 2018.

9.

Miniemulsion ARGET ATRP via Interfacial and Ion-Pair Catalysis: From ppm to ppb of Residual Copper.

Wang Y, Lorandi F, Fantin M, Chmielarz P, Isse AA, Gennaro A, Matyjaszewski K.

Macromolecules. 2017 Nov 14;50(21):8417-8425. doi: 10.1021/acs.macromol.7b01730. Epub 2017 Nov 3.

10.

Electrochemically Mediated Reversible Addition-Fragmentation Chain-Transfer Polymerization.

Wang Y, Fantin M, Park S, Gottlieb E, Fu L, Matyjaszewski K.

Macromolecules. 2017 Oct 24;50(20):7872-7879. doi: 10.1021/acs.macromol.7b02005. Epub 2017 Oct 13.

11.

Direct ATRP of Methacrylic Acid with Iron-Porphyrin Based Catalysts.

Fu L, Simakova A, Fantin M, Wang Y, Matyjaszewski K.

ACS Macro Lett. 2018 Jan 16;7(1):26-30. doi: 10.1021/acsmacrolett.7b00909. Epub 2017 Dec 14.

12.

Externally controlled atom transfer radical polymerization.

Pan X, Fantin M, Yuan F, Matyjaszewski K.

Chem Soc Rev. 2018 Jul 17;47(14):5457-5490. doi: 10.1039/c8cs00259b. Review.

PMID:
29868657
13.

Ab Initio Emulsion Atom-Transfer Radical Polymerization.

Lorandi F, Wang Y, Fantin M, Matyjaszewski K.

Angew Chem Int Ed Engl. 2018 Jul 2;57(27):8270-8274. doi: 10.1002/anie.201804647. Epub 2018 May 30.

PMID:
29845718
14.

Synergy between Electrochemical ATRP and RAFT for Polymerization at Low Copper Loading.

Wang Y, Fantin M, Matyjaszewski K.

Macromol Rapid Commun. 2018 Jun;39(12):e1800221. doi: 10.1002/marc.201800221. Epub 2018 May 11.

PMID:
29749017
15.

Mechanism of Supplemental Activator and Reducing Agent Atom Transfer Radical Polymerization Mediated by Inorganic Sulfites: Experimental Measurements and Kinetic Simulations.

Krys P, Fantin M, Mendonça PV, Abreu CMR, Guliashvili T, Rosa J, Santos LO, Serra AC, Matyjaszewski K, Coelho JFJ.

Polym Chem. 2017 Nov 14;8(42):6506-6519. doi: 10.1039/C7PY01319A. Epub 2017 Sep 22.

16.

Synthesis and Characterization of the Most Active Copper ATRP Catalyst Based on Tris[(4-dimethylaminopyridyl)methyl]amine.

Ribelli TG, Fantin M, Daran JC, Augustine KF, Poli R, Matyjaszewski K.

J Am Chem Soc. 2018 Jan 31;140(4):1525-1534. doi: 10.1021/jacs.7b12180. Epub 2018 Jan 22.

PMID:
29320170
17.

Harnessing the interaction between surfactant and hydrophilic catalyst to control eATRP in miniemulsion.

Fantin M, Chmielarz P, Wang Y, Lorandi F, Isse AA, Gennaro A, Matyjaszewski K.

Macromolecules. 2017 May 9;50(9):3726-2732. doi: 10.1021/acs.macromol.7b00530. Epub 2017 Apr 25.

18.

Electrochemical Atom Transfer Radical Polymerization in Miniemulsion with a Dual Catalytic System.

Fantin M, Park S, Wang Y, Matyjaszewski K.

Macromolecules. 2016 Nov 14;49(23):8838-8847. doi: 10.1021/acs.macromol.6b02037. Epub 2016 Dec 13.

19.

Sustainable Electrochemically-Mediated Atom Transfer Radical Polymerization with Inexpensive Non-Platinum Electrodes.

Fantin M, Lorandi F, Isse AA, Gennaro A.

Macromol Rapid Commun. 2016 Aug;37(16):1318-22. doi: 10.1002/marc.201600237. Epub 2016 Jun 22.

PMID:
27333068
20.

Atom Transfer Radical Polymerization of Methacrylic Acid: A Won Challenge.

Fantin M, Isse AA, Venzo A, Gennaro A, Matyjaszewski K.

J Am Chem Soc. 2016 Jun 15;138(23):7216-9. doi: 10.1021/jacs.6b01935. Epub 2016 May 31.

PMID:
27244091
21.

Clinical and Paraclinical Indicators of Motor System Impairment in Hereditary Spastic Paraplegia: A Pilot Study.

Martinuzzi A, Montanaro D, Vavla M, Paparella G, Bonanni P, Musumeci O, Brighina E, Hlavata H, Rossi G, Aghakhanyan G, Martino N, Baratto A, D'Angelo MG, Peruch F, Fantin M, Arnoldi A, Citterio A, Vantaggiato C, Rizzo V, Toscano A, Bresolin N, Bassi MT.

PLoS One. 2016 Apr 14;11(4):e0153283. doi: 10.1371/journal.pone.0153283. eCollection 2016.

22.

Mechanism of Photoinduced Metal-Free Atom Transfer Radical Polymerization: Experimental and Computational Studies.

Pan X, Fang C, Fantin M, Malhotra N, So WY, Peteanu LA, Isse AA, Gennaro A, Liu P, Matyjaszewski K.

J Am Chem Soc. 2016 Feb 24;138(7):2411-25. doi: 10.1021/jacs.5b13455. Epub 2016 Feb 12.

PMID:
26820243
23.
24.

Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations.

van der Kooij MA, Fantin M, Rejmak E, Grosse J, Zanoletti O, Fournier C, Ganguly K, Kalita K, Kaczmarek L, Sandi C.

Nat Commun. 2014 Sep 18;5:4995. doi: 10.1038/ncomms5995.

25.

Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.

Fernagut PO, Meissner WG, Biran M, Fantin M, Bassil F, Franconi JM, Tison F.

Synapse. 2014 Mar;68(3):98-106. doi: 10.1002/syn.21719. Epub 2013 Nov 15.

PMID:
24243499
26.

Impaired hippocampal neuroligin-2 function by chronic stress or synthetic peptide treatment is linked to social deficits and increased aggression.

van der Kooij MA, Fantin M, Kraev I, Korshunova I, Grosse J, Zanoletti O, Guirado R, Garcia-Mompó C, Nacher J, Stewart MG, Berezin V, Sandi C.

Neuropsychopharmacology. 2014 Apr;39(5):1148-58. doi: 10.1038/npp.2013.315. Epub 2013 Nov 11.

27.

A key role for nectin-1 in the ventral hippocampus in contextual fear memory.

Fantin M, van der Kooij MA, Grosse J, Krummenacher C, Sandi C.

PLoS One. 2013;8(2):e56897. doi: 10.1371/journal.pone.0056897. Epub 2013 Feb 13.

28.

A peptide mimetic targeting trans-homophilic NCAM binding sites promotes spatial learning and neural plasticity in the hippocampus.

Kraev I, Henneberger C, Rossetti C, Conboy L, Kohler LB, Fantin M, Jennings A, Venero C, Popov V, Rusakov D, Stewart MG, Bock E, Berezin V, Sandi C.

PLoS One. 2011;6(8):e23433. doi: 10.1371/journal.pone.0023433. Epub 2011 Aug 24.

29.

NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid.

Fantin M, Morari M, Tison F, Fernagut PO.

Neurol Res. 2011 May;33(4):444-7. doi: 10.1179/1743132810Y.0000000002.

PMID:
21535946
30.

Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations.

Arnoldi A, Crimella C, Tenderini E, Martinuzzi A, D'Angelo MG, Musumeci O, Toscano A, Scarlato M, Fantin M, Bresolin N, Bassi MT.

Clin Genet. 2012 Feb;81(2):150-7. doi: 10.1111/j.1399-0004.2011.01624.x. Epub 2011 Jan 31.

PMID:
21214876
31.

Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.

Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN, Caparrotta L, Martinuzzi A, Ragazzi E, Ghelli A, Sadun AA, d'Amati G, Carelli V.

Brain. 2011 Jan;134(Pt 1):220-34. doi: 10.1093/brain/awq276. Epub 2010 Oct 13.

32.

Dennexin peptides modeled after the homophilic binding sites of the neural cell adhesion molecule (NCAM) promote neuronal survival, modify cell adhesion and impair spatial learning.

Køhler LB, Christensen C, Rossetti C, Fantin M, Sandi C, Bock E, Berezin V.

Eur J Cell Biol. 2010 Nov;89(11):817-27. doi: 10.1016/j.ejcb.2010.07.007. Epub 2010 Aug 8.

PMID:
20692716
33.

Differential impact of polysialyltransferase ST8SiaII and ST8SiaIV knockout on social interaction and aggression.

Calandreau L, Márquez C, Bisaz R, Fantin M, Sandi C.

Genes Brain Behav. 2010 Nov;9(8):958-67. doi: 10.1111/j.1601-183X.2010.00635.x.

34.

Chemical and statistical characterization of selected documents from the archives of the Palazzo Ducale (Venice, Italy).

Gambaro A, Ganzerla R, Fantin M, Cappelletto E, Piazza R, Cairns W.

Anal Chim Acta. 2009 Oct 5;651(2):139-48. doi: 10.1016/j.aca.2009.08.023. Epub 2009 Aug 21.

PMID:
19782804
35.

In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.

Quintieri L, Fantin M, Palatini P, De Martin S, Rosato A, Caruso M, Geroni C, Floreani M.

Biochem Pharmacol. 2008 Sep 15;76(6):784-95. doi: 10.1016/j.bcp.2008.07.003. Epub 2008 Jul 11.

PMID:
18671948
36.

Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids.

Sala G, Trombin F, Beretta S, Tremolizzo L, Presutto P, Montopoli M, Fantin M, Martinuzzi A, Carelli V, Ferrarese C.

J Neurosci Res. 2008 Nov 15;86(15):3331-7. doi: 10.1002/jnr.21773.

PMID:
18615737
37.
38.

Solid lipid nanoparticles as delivery systems for bromocriptine.

Esposito E, Fantin M, Marti M, Drechsler M, Paccamiccio L, Mariani P, Sivieri E, Lain F, Menegatti E, Morari M, Cortesi R.

Pharm Res. 2008 Jul;25(7):1521-30. doi: 10.1007/s11095-007-9514-y. Epub 2008 Jan 3.

PMID:
18172580
39.

NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.

Fantin M, Marti M, Auberson YP, Morari M.

J Neurochem. 2007 Dec;103(6):2200-11. Epub 2007 Nov 6.

40.

Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.

Fantin M, Fischetti C, Trapella C, Morari M.

Br J Pharmacol. 2007 Oct;152(4):549-55. Epub 2007 Jul 9.

41.

Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.

Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.

J Pharmacol Exp Ther. 2007 Jun;321(3):961-7. Epub 2007 Feb 28.

PMID:
17329552
42.

Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

Quintieri L, Fantin M, Vizler C.

Adv Exp Med Biol. 2007;593:95-104. Review.

PMID:
17265720
43.

Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties.

Fantin M, Quintieri L, Kúsz E, Kis E, Glavinas H, Floreani M, Padrini R, Duda E, Vizler C.

Eur J Pharmacol. 2006 Mar 27;535(1-3):301-9. Epub 2006 Mar 20.

PMID:
16545799
44.

Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.

Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J, Di Benedetto M, Buzas B, Reinscheid RK, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox BM, Morari M.

J Neurosci. 2005 Oct 19;25(42):9591-601.

45.
46.

Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes.

Quintieri L, Geroni C, Fantin M, Battaglia R, Rosato A, Speed W, Zanovello P, Floreani M.

Clin Cancer Res. 2005 Feb 15;11(4):1608-17.

47.

Antispasmodic effect of amiodarone on gastrointestinal smooth muscle: possible involvement of calcium.

Gaion RM, Basadonna O, Santostasi G, Fantin M, Maragno I, Dorigo P.

Arch Int Pharmacodyn Ther. 1988 Jul-Aug;294:112-24.

PMID:
3233045
48.

Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.

Santostasi G, Fantin M, Maragno I, Gaion RM, Basadonna O, Dalla-Volta S.

J Cardiovasc Pharmacol. 1987 Apr;9(4):385-90.

PMID:
2438499
49.

[Retinoschisis, edema or cystoid degeneration of the retina? Current data on its physiopathology].

Metge MP, Bérard-Badier M, Fantin MJ.

Bull Soc Ophtalmol Fr. 1977 Mar;77(3):325-7. French. No abstract available.

PMID:
606401

Supplemental Content

Loading ...
Support Center